SELENOS

Last update 08 May 2025

Basic Info

Synonyms

AD-015, MGC2553, SBBI8

+ [6]

Introduction

Involved in the degradation process of misfolded endoplasmic reticulum (ER) luminal proteins. Participates in the transfer of misfolded proteins from the ER to the cytosol, where they are destroyed by the proteasome in a ubiquitin-dependent manner. Probably acts by serving as a linker between DERL1, which mediates the retrotranslocation of misfolded proteins into the cytosol, and the ATPase complex VCP, which mediates the translocation and ubiquitination.

100 Clinical Results associated with SELENOS

100 Translational Medicine associated with SELENOS

0 Patents (Medical) associated with SELENOS

299

Literatures (Medical) associated with SELENOS

01 May 2025·Experimental Eye Research

Investigation and validation of genes associated with endoplasmic reticulum stress in diabetic retinopathy using various machine learning algorithms

Article

Author: Yu, Yanqin ; Cao, Yaodan ; Zheng, Limin ; Yuan, Songtao ; Guo, Tianqi ; Hao, Jinqi ; Lu, Wuyun

BACKGROUNDDiabetic retinopathy (DR) is a common complication of diabetes, with Endoplasmic reticulum stress (ERS) playing a key role in cellular adaptation, injury, or apoptosis, impacting disease pathology. This study aimed to identify early diagnostic markers for personalized DR treatment.METHODSDR and healthy control (HC) samples were collected from the Gene Expression Omnibus (GEO) database. Differentially expressed ERS-related genes (DE-ERSRGs) were identified, and machine learning algorithms were used to pinpoint DR-specific feature DE-ERSRGs (FDE-ERSRGs). Diagnostic accuracy was assessed using ROC curve analysis. Further analyses included differential expression, co-expression, GO functional, KEGG pathway enrichment, and immune cell infiltration profiling in DR.RESULTSA total of 55 DE-ERSRGs were initially identified, and after further analysis, two key FDE-ERSRGs, SELENOS and heat shock protein family A member 5 (HSPA5), were highlighted due to their robust differential expression patterns between DR and healthy controls. Both genes exhibited high diagnostic potential, with AUC values of 0.792 and 0.799, respectively, indicating their promise as biomarkers for DR. Additionally, we examined the differential and co-expression patterns of DE-ERSRGs between high- and low-expression groups. We investigated the molecular functions and biological pathways associated with DR, analyzed immune cell infiltration differences between DR and HC groups, and assessed their correlation with FDE-ERSRGs.CONCLUSIONSOur findings provide new insights into the molecular mechanisms and metabolic pathways involved in DR, potentially paving the way for the identification of novel diagnostic and immunotherapeutic biomarkers.

01 Apr 2025·Multiple Sclerosis Journal

Presence of slowly expanding lesions in multiple sclerosis predicts progressive demyelination within lesions and normal-appearing tissue over time

Article

Author: Kolind, Shannon ; Bonati, Ulrike ; Gaetano, Laura ; Magon, Stefano ; Elliott, Colm ; Traboulsee, Anthony ; Clayton, David ; Vavasour, Irene ; Arnold, Douglas L ; Bernasconi, Carrado

Background:Multiple sclerosis (MS) slowly expanding lesions (SELs) are defined on magnetic resonance imaging (MRI) as contiguous regions of pre-existing focal non-contrast-enhancing T2 lesions with constant and concentric local expansion on conventional T1-weighted and T2-weighted images. SELs are associated with an increased risk of disability progression.Methods:Myelin-related changes detected using myelin water fraction (MWF) and magnetisation transfer ratio (MTR) in SELs and T2 lesions were measured over 192 weeks in participants with relapsing MS.Results:In participants with SELs (SEL+), SELs (MWF: 0.12 ± 0.03, MTR: 33.1 ± 3.6 pu) showed reduced myelin measures at baseline compared to T2 lesions (MWF: 0.13 ± 0.02, MTR: 35.1 ± 2.4 pu). In participants without SELs (SEL−), T2 lesions had higher myelin measures (MWF: 0.15 ± 0.02, MTR: 36.2 ± 2.0 pu) compared to T2 lesions in SEL+. Over 4 years, only SELs showed decreases in MWF (−11.4%). The percentage of abnormal voxels within normal-appearing white matter was higher in SEL+ and increased over time (SEL+ MWF Week 0: 0.56%, Week 192: 0.98%; SEL− MWF Week 0: 0.13%, Week 192: 0.25%).Conclusion:Our results indicate progressive focal and global demyelination in SEL+ participants and that the presence of SELs might be a biomarker for participants with ongoing diffuse or smouldering inflammation within the whole brain.

01 Feb 2025·Annals of Neurology

RNA Binding Protein Dysfunction Links Smoldering/Slowly Expanding Lesions to Neurodegeneration in Multiple Sclerosis

Article

Author: Levin, Michael C. ; Popescu, Bogdan F. ; Messmer, Miranda L. ; Salapa, Hannah E.

ObjectiveDespite the advances in treatments for multiple sclerosis (MS), unremitting neurodegeneration continues to drive disability and disease progression. Smoldering/slowly expanding lesions (SELs) and dysfunction of the RNA binding protein (RBP) heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) are pathologic hallmarks of MS cortex and intricately tied to disability and neurodegeneration, respectively. We hypothesized that neuronal hnRNP A1 dysfunction contributes to neurodegeneration and is exacerbated by smoldering/SELs in progressive MS.MethodsNeuronal hnRNP A1 pathology (nucleocytoplasmic mislocalization of hnRNP A1) was examined in healthy control and MS brains using immunohistochemistry. MS cases were stratified by severity of hnRNP A1 pathology to examine the link between RBP dysfunction, demyelination, and neurodegeneration.ResultsWe found that smoldering/SELs were only present within a subset of MS tissues characterized by elevated neuronal hnRNP A1 pathology (MS‐A1high) in adjacent cortical gray matter. In contrast to healthy controls and MS with low hnRNP A1 pathology (MS‐A1low), MS‐A1high showed elevated markers of neurodegeneration, including neuronal loss and injury, brain atrophy, axonal loss, and axon degeneration. Additionally, we discovered a subpopulation of morphologically intact neurons lacking expression of NeuN, a neuron‐specific RBP, in cortical projection neurons in MS‐A1high cases.InterpretationhnRNP A1 dysfunction contributes to neurodegeneration and may be exacerbated by smoldering/SELs in progressive MS. The discovery of NeuN‐negative neurons suggests that some cortical neurons may only be injured and not lost. By characterizing RBP pathology in MS cortex, this study has important implications for understanding the pathogenic mechanisms driving neurodegeneration, the substrate of disability and disease progression. ANN NEUROL 2025;97:313–328

Analysis

Perform a panoramic analysis of this field.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

SELENOS

Basic Info

Related

Analysis